Home / Market Research / Preterm Birth And PROM Testing Market By Test Type (Pelvic Exam, Ferning Test, Nitrazine Test, Pooling Test, Ultrasound Test, Uterine Monitoring Test, Biomarkers) - Growth, Future Prospects & Competitive Analysis, 2018 – 2026

Preterm Birth And PROM Testing Market By Test Type (Pelvic Exam, Ferning Test, Nitrazine Test, Pooling Test, Ultrasound Test, Uterine Monitoring Test, Biomarkers) - Growth, Future Prospects & Competitive Analysis, 2018 – 2026


Published: Mar 2019

Industry Outlook

The preterm birth and PROM testing market is set to reach from US$ 996.3 Mn in 2017 to US$ 1,201.2 Mn by 2026 representing slow growth at a compounded annual growth rate (CAGR) of 2.1% during the forecast period from 2018 to 2026. As per the research findings of World Health Organization (WHO), annually 15 million babies are born before the completion of 37 weeks of normal pregnancy and as a result approximately 1 million children die every year due to complications associated with preterm births.

Excellent diagnostic accuracy and sensitivity will increase the popularity of biomarkers as PROM testing kits

Physicians investigate preliminary symptoms such as vaginal bleeding, vaginal discharge, pelvic pressure etc., to confirm preterm birth complications. Pelvic examination is the first line of diagnostic approach which is performed several times over a period of time to study the contraction and changes of cervix. If the cervix begins to soften, dilate and become thin before 37 weeks of pregnancy the patient is diagnosed with preterm labor. Biomarkers such as Alpha-fetoprotein test (AFT), insulin like growth factor binding protein-1 (IGFBP-1), placental alpha macroglobulin-1 (PAMG-1) etc., are gaining tremendous attention in the last decade. Excellent diagnostic accuracy and sensitivity increases the popularity of biomarkers as PROM testing kits.

"Rising incidence of premature births and increasing maternal health awareness together drive the market growth in North America region"

In the present scenario North America is leading the regional segment for preterm birth and PROM testing market with a share of 36%. Annually 3.9 million babies are born in North America of which 12.0% are born prematurely. Rising incidence of premature births and increasing maternal health awareness together drive the market growth in North America region. Existence of major players such as Abbott Laboratories, Inc., CooperSurgical, Inc., Qiagen, Inc., Hologic, Inc. etc. further propel the market growth in North America region. Europe is the second largest market with a share of 28% on account of supportive regulatory environment provided by the European Medical Agency (EMA) for PROM testing kits and establishment of well-developed healthcare infrastructure. Asia Pacific currently holds 15% market share and will be showcasing rapid growth in the near future owing to increasing complication related to pregnancy and proactive government initiatives to provide optimum maternal care.

Historical & Forecast Period

This research report presents the analysis of each segment from 2016 to 2026 considering 2017 as the base year for the research. Compounded annual growth rate (CAGR) for each respective segments are calculated for the forecast period from 2018 to 2026.

Report Scope by Segments

The market is segmented by test type and by geography. 

ATTRIBUTE DETAILS
Research Period  2017-2027
Base Year 2018
Forecast Period  2019-2027
Historical Year  2017
Unit  USD Million
Segmentation

 By Test Type (2016–2026; US$ Mn)
 • Pelvic Exam
 • Ferning Test
 • Nitrazine Test
 • Pooling Test
 • Ultrasound Test
 • Uterine Monitoring Test
 • Biomarkers

 Geography Segment (2016–2026; US$ Mn)
 • North America (U.S., Canada)
 • Europe (U.K., Germany, Rest of Europe)
 • Asia Pacific (China, Japan, Rest of APAC)
 • Latin America (Brazil, Mexico, Rest of Latin America)
 • Middle East and Africa (GCC, Rest of the Middle East and Africa)

Biopharmaceutical companies specializing in manufacturing preterm birth and PROM testing kits are Abbott Laboratories, Inc., Biosynex, Clinical Innovations, LLC, CooperSurgical, Inc., Hologic, Inc., IQ Products, Medixbiochemica, NX Prenatal, Inc., Qiagen N.V. and Sera Prognostics, Inc.

Key questions answered in this report

  • What will be the market assessment for preterm birth and prom testing market?
  • What are the major symptoms associated with preterm labor and premature ruptures of membranes?
  • Which major biopharmaceutical companies are actively engaged in the production of PROM testing test?
  • What is the significance of pelvic examination during preterm labor?
  • Which factors are responsible for the popularity of biomarkers as a diagnostic kit during for PROM?
  • What is the current share of North America and its performance in the near future?

TABLE 1 : Global Preterm Birth and PROM Testing Market Portraiture
TABLE 2 : Global Preterm Birth and PROM Testing Market, by Test Type, 2016 – 2026 (US$ Mn)
TABLE 3 : Global Preterm Birth and PROM Testing Market, by Geography, 2016 – 2026 (US$ Mn)
TABLE 4 : North America Preterm Birth and PROM Testing Market, by Test Type, 2016 – 2026 (US$ Mn)
TABLE 5 : North America Preterm Birth and PROM Testing Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 6 : Europe Preterm Birth and PROM Testing Market, by Test Type, 2016 – 2026 (US$ Mn)
TABLE 7 : Europe Preterm Birth and PROM Testing Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 8 : Asia Pacific Preterm Birth and PROM Testing Market, by Test Type, 2016 – 2026 (US$ Mn)
TABLE 9 : Asia Pacific Preterm Birth and PROM Testing Market, by Country/Region, 2015 – 2025 (US$ Mn)
TABLE 10 : Latin America Preterm Birth and PROM Testing Market, by Test Type, 2016 – 2026 (US$ Mn)
TABLE 11 : Latin America Preterm Birth and PROM Testing Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 12 : Middle East and Africa Preterm Birth and PROM Testing Market, by Test Type, 2016 – 2026 (US$ Mn)
TABLE 13 : Middle East and Africa Preterm Birth and PROM Testing Market, by Region, 2016 – 2026 (US$ Mn)
TABLE 14 : Abbott Laboratories, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 15 : Biosynex: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 16 : Clinical Innovations, LLC: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 17 : CooperSurgical, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 18 : Hologic, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 19 : IQ Products: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 20 : Medixbiochemica: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 21 : NX Prenatal, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 22 : Qiagen N.V.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 23 : Sera Prognostics, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)

Choose License Type
 
Contact Information
24/7 Research Support
Phone: +1-855-455-8662
sales@acutemarketreports.com
Get in Touch with us
join us on Facebook
Follow us on Twitter
Follow us on LinkedIn
Add us on Google +